Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study-Reference-Cited by-同舟云学术

Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study

Published:2020-01-06 Issue:2 Volume:16 Page:292-304
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Brosseron Frederic¹²,Kolbe Carl‐Christian³,Santarelli Francesco¹²,Carvalho Stephanie⁴,Antonell Anna⁵,Castro‐Gomez Sergio¹,Tacik Pawel¹,Namasivayam Aishwarya Alex⁶,Mangone Graziella⁴,Schneider Reinhard⁶,Latz Eicke²³,Wüllner Ullrich²⁷,Svenningsson Per⁸,Sánchez‐Valle Raquel⁵,Molinuevo José Luis⁹,Corvol Jean‐Christophe⁴,Heneka Michael T.¹²,

Affiliation:

1. Department of Neurodegenerative Diseases & Geropsychiatry/Neurology University of Bonn Medical Center Bonn Germany

2. German Center for Neurodegenerative Diseases (DZNE) Bonn Germany

3. University of Bonn Medical Center Institute of Innate Immune Bonn Germany

4. Institut du Cerveau et de la Moelle épinière, Sorbonne Université, Assistance‐Publique Hôpitaux de Paris, INSERM, UMRS 1127, CNRS, UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Hôpital Pitié‐Salpêtrière, Department of Neurology, Centre d'Investigation Clinique Neurosciences Paris France

5. Alzheimer's disease and other cognitive disorders Unit, Hospital Clínic, Fundació Clínic per a la Recerca Biomèdica Institut d'Investigacions Biomè; diques August Pi i Sunyer (IDIBAPS) Barcelona Spain

6. Luxembourg Centre for Systems Biomedicine (LCSB) University of Luxembourg Campus Belval Belvaux Luxembourg

7. Department of Neurology University of Bonn Medical Center Bonn Germany

8. Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden

9. Barcelonabeta Brain Research Center, Pasqual Maragall Foundation Barcelona Spain

Funder

Innovative Medicines Initiative

Seventh Framework Program

FP7

EFPIA

German Center for Neurodegenerative Diseases

DZNE

Helmholtz Association

German Research Council

DFG

Deutsche Forschungsgemeinschaft

Generalitat de Catalunya

Pla estratègic de recerca i innovació en salut

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2019.07.018

Reference34 articles.

1. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

2. Current state of Alzheimer’s fluid biomarkers

3. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

4. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

5. When is Alzheimer's not dementia‐Cochrane commentary on The National Institute on Ageing and Alzheimer's Association Research Framework for Alzheimer's Disease;McCleery J;Age Ageing,2018

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer’s Disease Patients;Journal of Alzheimer's Disease;2024-09-10

2. Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation;Alzheimer's Research & Therapy;2024-07-31

3. CSF complement proteins are elevated in prodromal to moderate AD patients and are not altered by the anti-tau antibody semorinemab;2024-04-15

4. Innate immune activation in neurodegenerative diseases;Immunity;2024-04

5. Microfluidic Isolation of Neuronal-Enriched Extracellular Vesicles Shows Distinct and Common Neurological Proteins in Long COVID, HIV Infection and Alzheimer’s Disease;International Journal of Molecular Sciences;2024-03-29